Compounds > methotrexate
Page last updated: 2024-08-25

methotrexate and Abnormal Karyotype

methotrexate has been researched along with Abnormal Karyotype in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Amigo, ML; Bravo-Perez, C; Escobar, H; Garcia, J; Garcia-Malo, MD; Muiña, B; Ortuño, FJ; Pajares, I; Piris, MA; Rodriguez-Pinilla, SM1
Alten, J; Behrens, YL; Bergmann, AK; Buchmann, S; Cario, G; Cazzaniga, G; Davenport, CF; Ebersold, J; Fazio, G; Göhring, G; Hagedorn, M; Hofmann, W; Lentes, J; Möricke, A; Schieck, M; Schlegelberger, B; Schrappe, M; Stanulla, M; Steinemann, D; Thomay, K1
Miyoshi, T; Nagai, K; Nesumi, N; Oshima, K; Sakai, T; Tamura, S1
Chia, WK; Julia, MI; Leong, CF; Salwati, S; Tang, YL; Wong, CL; Yap, EC1

Other Studies

4 other study(ies) available for methotrexate and Abnormal Karyotype

ArticleYear
Double hit B cell precursor leukemia/lymphoma in a patient with a prior diagnosis of follicular lymphoma: a diagnostic and therapeutic dilemma.
    Annals of hematology, 2020, Volume: 99, Issue:2

    Topics: Abnormal Karyotype; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Biopsy; Cyclophosphamide; Disease Progression; DNA Nucleotidylexotransferase; Doxorubicin; Fatal Outcome; Female; Humans; Lymphoma, Follicular; Mercaptopurine; Methotrexate; Middle Aged; Pancytopenia; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Rituximab; Salvage Therapy; Splenic Rupture; Splenomegaly; Stomach; Vincristine

2020
Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia.
    Annals of hematology, 2020, Volume: 99, Issue:4

    Topics: Abnormal Karyotype; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Comparative Genomic Hybridization; Cyclophosphamide; Cytarabine; Daunorubicin; Genes, Neoplasm; Humans; Ikaros Transcription Factor; In Situ Hybridization, Fluorescence; Mercaptopurine; Methotrexate; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Risk Factors; RNA, Messenger; RNA, Neoplasm; Sequence Analysis, RNA; Transcriptome; Vincristine; Workflow

2020
Development of myeloid sarcoma after long-term methotrexate use for rheumatoid arthritis.
    International journal of hematology, 2014, Volume: 99, Issue:4

    Topics: Abnormal Karyotype; Aged; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Chromosome Banding; Female; Humans; Immunophenotyping; Immunosuppressive Agents; Methotrexate; Neoplasms, Second Primary; Phenotype; Positron-Emission Tomography; Sarcoma, Myeloid; Tomography, X-Ray Computed

2014
Dismal outcome of therapy-related myeloid neoplasm associated with complex aberrant karyotypes and monosomal karyotype: a case report.
    The Malaysian journal of pathology, 2016, Volume: 38, Issue:3

    Topics: Abnormal Karyotype; Antineoplastic Combined Chemotherapy Protocols; Humans; Idarubicin; In Situ Hybridization, Fluorescence; Karyotyping; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Tretinoin

2016